➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Mallinckrodt
Medtronic
Baxter
Colorcon

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CIPROFLOXACIN; DEXAMETHASONE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for ciprofloxacin; dexamethasone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00477412 Bortezomib (Velcade) Plus Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma Active, not recruiting Millennium Pharmaceuticals, Inc. Phase 1 2007-04-01 The goal of this clinical research study is to learn if bortezomib (in combination with rituximab plus 2 different intensive chemotherapy regimens) can help to control the disease in patients with mantle cell lymphoma. The safety of these drug combinations will also be studied.
NCT00477412 Bortezomib (Velcade) Plus Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma Active, not recruiting M.D. Anderson Cancer Center Phase 1 2007-04-01 The goal of this clinical research study is to learn if bortezomib (in combination with rituximab plus 2 different intensive chemotherapy regimens) can help to control the disease in patients with mantle cell lymphoma. The safety of these drug combinations will also be studied.
NCT00945802 FST-201 In The Treatment of Acute Otitis Externa Terminated Shire Phase 3 2009-07-01 The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This trial is designed to enable filing of a New Drug Application in support of FST-201 for the indication of acute otitis externa.
NCT00956748 N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media Not yet recruiting St. Paul's Hospital, Canada Phase 4 2016-06-01 Chronic suppurative otitis media (CSOM) can be particularly difficult to treat as a number of patients do not respond to routine antibiotic or surgical treatments. The current treatment involves administering combination antibiotic anti-inflammatory ear drops such as Ciprodex (ciprofloxacin 0.3% / dexamethasone 0.1%). Although most patients experience a relief of symptoms, a fraction of patients remain refractory to treatment. Recent findings suggest that the addition of N-acetylcysteine (0.5-2%) to Ciprodex is a superior treatment for otitis media with effusion compared to the use of Ciprodex alone.
NCT00961675 FST-201 in the Treatment of Acute Otitis Externa Completed Shire Phase 3 2009-08-01 The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This study will be conducted at one site, the LBJ Tropical Medical Center, Department of Otolaryngology, in Pago Pago, American Samoa.
NCT01277016 A Trial for Systemic Light-chain (AL) Amyloidosis Completed European Myeloma Network Phase 3 2011-01-01 In this multi-center phase III trial, untreated patients diagnosed with AL who are not candidates for stem cell transplant with melphalan 200 mg/m2 are the target population. Stage I and II patients will be eligible. Stage III patients will be enrolled in an ancillary phase II study. Eligible patients will be stratified as cardiac stage I or stage II and then randomized to receive MDex or BMDex. Primary objective is to compare hematologic(clonal) response i.e. the rate of complete response (CR) + partial response (PR) defined according to the criteria of the International Society for Amyloidosis consensus.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ciprofloxacin; dexamethasone

Condition Name

Condition Name for ciprofloxacin; dexamethasone
Intervention Trials
Acute Otitis Externa 3
Lymphoma 2
Otitis Externa 2
Otorrhea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ciprofloxacin; dexamethasone
Intervention Trials
Otitis 7
Otitis Externa 5
Lymphoma 3
Otitis Media 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ciprofloxacin; dexamethasone

Trials by Country

Trials by Country for ciprofloxacin; dexamethasone
Location Trials
United States 32
Italy 1
Brazil 1
American Samoa 1
Puerto Rico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ciprofloxacin; dexamethasone
Location Trials
Florida 3
North Carolina 3
Texas 3
Oregon 2
California 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ciprofloxacin; dexamethasone

Clinical Trial Phase

Clinical Trial Phase for ciprofloxacin; dexamethasone
Clinical Trial Phase Trials
Phase 4 2
Phase 3 6
Phase 2 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ciprofloxacin; dexamethasone
Clinical Trial Phase Trials
Completed 5
Terminated 3
Recruiting 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ciprofloxacin; dexamethasone

Sponsor Name

Sponsor Name for ciprofloxacin; dexamethasone
Sponsor Trials
Par Pharmaceutical, Inc. 2
Novum Pharmaceutical Research Services 2
Shire 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ciprofloxacin; dexamethasone
Sponsor Trials
Industry 12
Other 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
McKesson
Medtronic
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.